Kathleen P. Gallagher - Jan 6, 2025 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Role: Chief Program Officer
Signature: /s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
Stock symbol: RNA
Transactions as of: Jan 6, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/8/2025, 08:16 PM
Next filing: Jan 23, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNA	Common Stock	Award	$0	+25K	+71.5%	$0.00	60K	Jan 6, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RNA	Stock Option (Right to Buy)	Award	$0	+50K		$0.00	50K	Jan 6, 2025	Common Stock	50K	$31.42	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four equal installments on the first four anniversaries of January 6, 2025, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F2	This option vests in 48 equal installments on each monthly anniversary of the grant date, until it is fully vested on January 6, 2029.